Improved Time to Treatment Failure and OS Are Observed in Patients With Longer Time to Metastasis
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Synchronous Versus Metachronous Metastatic Disease: Impact of Time to Metastasis on Patient Outcome-Results From the International Metastatic Renal Cell Carcinoma Database Consortium
Eur Urol Oncol 2020 Feb 06;[EPub Ahead of Print], F Donskov, W Xie, A Overby, JC Wells, AP Fraccon, CS Sacco, C Porta, I Stukalin, JL Lee, K Koutsoukos, T Yuasa, ID Davis, C Pezaro, R Kanesvaran, GA Bjarnason, HW Sim, N Rathi, CK Kollmannsberger, CM Canil, TK Choueiri, DYC HengFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.